News

June 4, 2019

Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma

June 4, 2019, Melbourne, Victoria – Aravax, a clinical stage biotechnology company focused on developing the first safe and rapidly effective treatment for pe...

Please reload

Archive
Please reload

Aravax


Tel: +61 (0)3 9657 0700
Email: info@aravax.com.au​
Address: Level 9, 31 Queen St

Melbourne, Victoria, 3000

Australia

Contact Us